Current PSA Monitoring Ignores Risk to Some Prostate Cancer Survivors
In older men who survived low-risk cancer and have limited life expectancy, frequent PSA screenings may do more harm than good
University of California San Francisco
Give to UCSFIn older men who survived low-risk cancer and have limited life expectancy, frequent PSA screenings may do more harm than good
Treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy.
UCSF scientists have invented a technique that lets them precisely and reversibly disrupt the action of specific cellular proteins at a microscopic scale by making them split apart when illuminated with blue light.
Researchers at UCSF have found a way to attack one of the most common drivers of lung, colorectal, and pancreatic cancer by targeting the proteins it produces on the outside of the cell.
Huang highlighted the microscopy work in his lab that has enabled a clearer understanding of the function of cells and the processes that underlie disease.
SF CAN is targeting the five most common cancers which collectively account for half of all new cancers in San Francisco.
UCSF: The Campaign is taking on the world’s most complex health challenges, powered by an exceptional community of mavericks, innovators, and advocates. Together we will make the Bay Area and our world healthier for all.
UCSF physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia will respond to treatment.
Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells.
UCSF researchers are leading several initiatives that aim to see how dozens of seemingly unrelated genes and proteins involved in a disease are in fact all part the same interconnected biological pathway.
New research finds one of the world’s most deadly forms of lung cancer is driven by changes in multiple different genes.
Smartphones and emotional crises, social media and tanning beds are seemingly disconnected – but UCSF researcher Eleni Linos has started to make an impact on health by her focus on how technology can influence our behaviors.
A study challenges the belief that children with Down syndrome are significantly more susceptible to leukemia.
One of UCSF’s groundbreaking cancer programs will be prominently featured at the 2017 Dreamforce conference through an interactive exposition and a talk by two researchers.
UCSF researchers have discovered a gene vulnerability that could let oncologists wipe out drug-resistant cancers across many different cancer types.
Scientists from Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and the University of California, San Francisco will hold a briefing to discuss Accelerating Therapeutics for Opportunities in Medicine
UCSF researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they are all using the same mechanism to remodel normal tissue and spread.
The NCI has announced that UCSF will host one of five new Cancer Drug Resistance and Sensitivity Centers being set up around the U.S. through funding from the 21st Century Cures Act of 2016.
Two UCSF scientists have been awarded NIH New Innovator Awards, which support unusually innovative research from early career investigators.
UCSF Benioff Children’s Hospital San Francisco has been certified as the first medical center in California to provide CAR-T therapy for children and young adults with acute lymphoblastic leukemia.
The University of California’s five academic cancer centers, have formed a consortium to better address California’s most pressing cancer-related problems and opportunities.
UCSF’s Helen Diller Family Comprehensive Cancer Center is consistently among the world's top five institutions producing the most impactful and utilized research.